T1	Participants 135 220	patients with naturally occurring common colds of less than or equal to 48 h duration
T2	Participants 55 87	naturally occurring common colds
T3	Participants 367 426	10-MU (n = 74), 20-MU (n = 74), and placebo (n = 72) groups
